[Screenshot asset suggestion: An infographic explaining the triple-agonist mechanism, showing GLP-1, GIP, and Glucagon receptors being activated and their subsequent effects on appetite, insulin, and thermogenesis.] The science of triple agonism The addition of the glucagon receptor agonist is what truly separates Retatrutide from twincretins like Tirzepatide (Mounjaro)
Some women find that combining semaglutide with other approaches achieves better weight loss results at lower semaglutide doses, which may reduce sexual side effects
Beyond that, transfer the medication to a cooler with ice packs (not direct contact)
ApoB, the single best blood marker of how many cholesterol-carrying particles you have, also tends to come down
Cost and the slow timeline come up a lot
Low GLP activity is often linked with obesity, insulin resistance, and type 2 diabetes